Hickey, Kevin J., <br/><br/>
Update, all eyes on Allergan  :  drug company's unprecedented move raises questions for patent and drug law.  Part I  / 
 All eyes on Allergan :  drug company's unprecedented move raises questions for patent and drug law.  Part I 
Kevin J. Hickey. 
 - [Library of Congress public edition]. 
 - 1 online resource. 
 - LSB ;  10009 .
 - Legal sidebar ;  LSB10009. .
<br/><br/> The CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141.  GPO Cataloging Record Distribution Program (CRDP). 
<br/><br/><label>LCCN: </label>2020231755 
<br/><br/><label>Subjects--Corporate Names: </label><br/>Allergan Pharmaceuticals--Trials, litigation, etc.<br/>United States. Patent and Trademark Office --Rules and practice.
<br/><br/><label>Subjects--Topical Terms: </label><br/>Patent laws and legislation--United States.<br/>Drugs--Law and legislation--United States.
<br/><br/><label>Subjects--Geographic Terms: </label><br/>Saint Regis Mohawk Tribe--Trials, litigation, etc.
<br/><br/><label>GPO Item No.: </label>0807-A-10 (online) 
<br/><br/><label>Gov. Doc. Class. No.: </label>LC 14.25:LSB 10009/